BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 20060399)

  • 1. ATR preferentially interacts with common fragile site FRA3B and the binding requires its kinase activity in response to aphidicolin treatment.
    Wan C; Kulkarni A; Wang YH
    Mutat Res; 2010 Apr; 686(1-2):39-46. PubMed ID: 20060399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interplay between ATM and ATR in the regulation of common fragile site stability.
    Ozeri-Galai E; Schwartz M; Rahat A; Kerem B
    Oncogene; 2008 Apr; 27(15):2109-17. PubMed ID: 17934520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired replication dynamics at the FRA3B common fragile site.
    Palakodeti A; Lucas I; Jiang Y; Young DJ; Fernald AA; Karrison T; Le Beau MM
    Hum Mol Genet; 2010 Jan; 19(1):99-110. PubMed ID: 19815620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ATR regulates fragile site stability.
    Casper AM; Nghiem P; Arlt MF; Glover TW
    Cell; 2002 Dec; 111(6):779-89. PubMed ID: 12526805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of hydroxyurea and aphidicolin on phosphorylation of ataxia telangiectasia mutated on Ser 1981 and histone H2AX on Ser 139 in relation to cell cycle phase and induction of apoptosis.
    Kurose A; Tanaka T; Huang X; Traganos F; Dai W; Darzynkiewicz Z
    Cytometry A; 2006 Apr; 69(4):212-21. PubMed ID: 16528719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of topoisomerase I prevents chromosome breakage at common fragile sites.
    Arlt MF; Glover TW
    DNA Repair (Amst); 2010 Jun; 9(6):678-89. PubMed ID: 20413351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xenopus ATR is a replication-dependent chromatin-binding protein required for the DNA replication checkpoint.
    Hekmat-Nejad M; You Z; Yee MC; Newport JW; Cimprich KA
    Curr Biol; 2000 Dec 14-28; 10(24):1565-73. PubMed ID: 11137007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Replication of a common fragile site, FRA3B, occurs late in S phase and is delayed further upon induction: implications for the mechanism of fragile site induction.
    Le Beau MM; Rassool FV; Neilly ME; Espinosa R; Glover TW; Smith DI; McKeithan TW
    Hum Mol Genet; 1998 Apr; 7(4):755-61. PubMed ID: 9499431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of unstable sequences within the common fragile site at 3p14.2: implications for the mechanism of deletions within fragile histidine triad gene/common fragile site at 3p14.2 in tumors.
    Corbin S; Neilly ME; Espinosa R; Davis EM; McKeithan TW; Le Beau MM
    Cancer Res; 2002 Jun; 62(12):3477-84. PubMed ID: 12067991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stably transfected common fragile site sequences exhibit instability at ectopic sites.
    Ragland RL; Glynn MW; Arlt MF; Glover TW
    Genes Chromosomes Cancer; 2008 Oct; 47(10):860-72. PubMed ID: 18615677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Replication stress induces tumor-like microdeletions in FHIT/FRA3B.
    Durkin SG; Ragland RL; Arlt MF; Mulle JG; Warren ST; Glover TW
    Proc Natl Acad Sci U S A; 2008 Jan; 105(1):246-51. PubMed ID: 18162546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of hypoxia-induced replication arrest with hydroxyurea and aphidicolin-induced arrest.
    Hammond EM; Green SL; Giaccia AJ
    Mutat Res; 2003 Nov; 532(1-2):205-13. PubMed ID: 14643437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress.
    Tibbetts RS; Cortez D; Brumbaugh KM; Scully R; Livingston D; Elledge SJ; Abraham RT
    Genes Dev; 2000 Dec; 14(23):2989-3002. PubMed ID: 11114888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the role of Fhit in suppression of DNA damage.
    Saldivar JC; Bene J; Hosseini SA; Miuma S; Horton S; Heerema NA; Huebner K
    Adv Biol Regul; 2013 Jan; 53(1):77-85. PubMed ID: 23102829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allele-specific late replication and fragility of the most active common fragile site, FRA3B.
    Wang L; Darling J; Zhang JS; Huang H; Liu W; Smith DI
    Hum Mol Genet; 1999 Mar; 8(3):431-7. PubMed ID: 9949202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Replication stress induces specific enrichment of RECQ1 at common fragile sites FRA3B and FRA16D.
    Lu X; Parvathaneni S; Hara T; Lal A; Sharma S
    Mol Cancer; 2013 Apr; 12(1):29. PubMed ID: 23601052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of Tousled-like kinase activity after DNA damage or replication block requires ATM, NBS1 and Chk1.
    Krause DR; Jonnalagadda JC; Gatei MH; Sillje HH; Zhou BB; Nigg EA; Khanna K
    Oncogene; 2003 Sep; 22(38):5927-37. PubMed ID: 12955071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positions of chromosome 3p14.2 fragile sites (FRA3B) within the FHIT gene.
    Zimonjic DB; Druck T; Ohta M; Kastury K; Croce CM; Popescu NC; Huebner K
    Cancer Res; 1997 Mar; 57(6):1166-70. PubMed ID: 9067288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Fhit-ing role in the DNA damage checkpoint response.
    Ishii H; Wang Y; Huebner K
    Cell Cycle; 2007 May; 6(9):1044-8. PubMed ID: 17457056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular parameters of genome instability: roles of fragile genes at common fragile sites.
    Pichiorri F; Ishii H; Okumura H; Trapasso F; Wang Y; Huebner K
    J Cell Biochem; 2008 Aug; 104(5):1525-33. PubMed ID: 18393361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.